News Novo says oral semaglutide works in diabetic kids Novo Nordisk will file oral formulations of its GLP-1 agonist semaglutide for children and adolescents with type 2 diabetes later this year.
News UK Biobank patient data placed on sale in China There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed for sale in China.
News Swiss franc strength puts Roche's results in a poor light Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.
News Sanofi welcomes incoming CEO with sales lift Sanofi's new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter.
News AbbVie makes record investment in North Carolina plant AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.
News MSD cuts $1bn AI tool deal with Google Cloud MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees worldwide.
News Biogen, Denali pull Parkinson's drug after failed trial Biogen has stopped development of Denali-partnered Parkinson's disease candidate BIIB122, after it failed to move the needle in a phase 2b trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.